NCT03526432 2025-10-24Phase II Study of Atezolizumab + Bevacizumab in Endometrial CancerUniversity of OklahomaPhase 2 Active not recruiting110 enrolled
NCT03694262 2025-05-30EndoBARRMedical College of WisconsinPhase 2 Active not recruiting30 enrolled 7 charts